| Application no. and date | 99935442.6 (espacenet) (Federated) (European Patent Register), 19990708 | | Patent/reg. no. and date | DK/EP 1115391, 20021009 | | Publication date | 20010718 | | Priority no. and date | US 101809 P, 19980925 | | EP pub. no. and date |
EP 1115391 20010718 | | Effective date | | | Applicant/owner | WARNER-LAMBERT COMPANY, 201 Tabor Road
Morris Plains
New Jersey 07950, US | | Applicant ref. no. | 111747 | | Inventor | GROVE, William, Richard, 10710 Indianola
Whitmore Lake, MI 48189, US,
KLOHS, Wayne, Daniel, 4559 Sycamore Drive
Ypsilanti, MI 48197, US,
MERRIMAN, Ronald, Lynn, 5929 Lohr Lake Court
Ann Arbor, MI 48108, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/505, A61K 31/70, A61K 33/24, A61P 35/00, A61K 31/165 | | Title | Kemoterapi af cancer med acetyldinalin i kombination med gemcitabin, capecitabin eller cisplatin | | Int. application no. | PCT/US99/15386 | | Int. publication no. | WO00018393 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
